CRISPR Nobel laureates win latest round of patent dispute
A long-running legal battle over patent rights for the Nobel-prize-winning CRISPR/Cas9 approach to genome editing has reignited...
An organism consisting of a cell or cells in which the genetic material is DNA packaged into chromosomes, and contained within a distinct nucleus. All animals, plants and fungi are eukaryotes.
A long-running legal battle over patent rights for the Nobel-prize-winning CRISPR/Cas9 approach to genome editing has reignited...
This piece by Vanessa Burns, exploring the impact the impact that CRISPR-based genome editing will have over the next 25 years, won the second prize in the inaugural Marcus Pembrey BioNews Writing Competition...
A new genome editing mechanism has been developed for the first time from a protein found in eukaryotes...
The Broad Institute, Cambridge, Massachusetts, has been awarded the US intellectual property rights for the use of CRISPR/Cas9 by a Patent and Trial Appeal Board...
The European Patent Office announced that it will uphold an earlier ruling to retract a key CRISPR/Cas9 patent held by the Broad Institute...
The US patent office has declared an 'interference' - re-opening the long-running dispute between the University of California (UC), Berkeley and the Broad Institute in Cambridge, Massachusetts, over who invented CRISPR genome editing first...
by Jen Willows
A US appeal court judgment in favour of the Broad Institute may mark the close of the long-running dispute over the US patent for the use of CRISPR/Cas9 in animal and plant cells...
by Jen Willows
Three scientists will share the US$1 million 2018 Kavli prize in Nanoscience 'for the invention of CRISPR-Cas9, a precise nanotool for editing DNA, causing a revolution in biology, agriculture, and medicine'...
After three years of intense legal battles over the patent rights to CRISPR genome editing technology, lawyers for the University of California Berkeley and the Broad Institute in Cambridge, Massachusetts faced off in court again...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.